Trial intelligence / Profile preview

Remimazolam vs propofol for anesthesia during radiofrequency catheter ablation in atrial fibrillation

ChiCTR2500099007Phase 4Completed

Sponsor
Shanghai First People's Hospital Jiuquan Hospital
Start
Mar 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in Atrial fibrillation (AFib) (2 arms), sponsored by Shanghai First People's Hospital Jiuquan Hospital. Primary endpoint: Number of respiratory depression cases. Started Mar 2025; status: completed.

02

Drugs

remimazolam
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on ChiCTR2500099007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500099007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call